Solventum Corporation (SOLV) Financials
SOLV Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 14.2 billion | 9.4 billion |
| June 30, 2026 | 14.2 billion | 9.4 billion |
| March 31, 2026 | 14.1 billion | 9.1 billion |
| Dec. 31, 2025 | 14.3 billion | 9.2 billion |
SOLV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | 99.0 million | 42.0 million |
| June 30, 2026 | 144.0 million | 38.0 million |
| March 31, 2026 | -273.0 million | 51.0 million |
| Dec. 31, 2025 | 32.0 million | 37.0 million |
SOLV Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | -12.0 million |
| June 30, 2026 | 92.0 million |
| March 31, 2026 | 13.0 million |
| Dec. 31, 2025 | 63.0 million |
SOLV Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 451.0 million | 4.6 billion | 206.0 million |
| June 30, 2026 | 403.0 million | 4.6 billion | 207.0 million |
| March 31, 2026 | 561.0 million | 4.6 billion | 207.0 million |
| Dec. 31, 2025 | 878.0 million | 5.0 billion | - |
SOLV Shares Outstanding
SOLV Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | 80.0 million | 181.0 million | 813.0 million | - |
| June 30, 2026 | 83.0 million | 178.0 million | 927.0 million | - |
| March 31, 2026 | 84.0 million | 189.0 million | 827.0 million | - |
| Dec. 31, 2025 | 63.0 million | 176.0 million | 759.0 million | - |
SOLV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 1.9 billion | 887.0 million |
| June 30, 2026 | 2.2 billion | 923.0 million |
| March 31, 2026 | 2.0 billion | 910.0 million |
| Dec. 31, 2025 | 2.0 billion | 1.0 billion |
SOLV Revenue by Segment
Graph available only for paid members. Upgrade to see it.
SOLV
Price: $86.32
52 week price:
Earnings Per Share: 0.88 USD
P/E Ratio: 100.70
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United Kingdom
Market Capitalization: 15.1 billion